A detailed history of Brinker Capital Investments, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Brinker Capital Investments, LLC holds 24,006 shares of DXCM stock, worth $1.39 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
24,006
Previous 27,225 11.82%
Holding current value
$1.39 Million
Previous $2.38 Million 32.03%
% of portfolio
0.01%
Previous 0.02%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

SELL
$66.46 - $89.53 $213,934 - $288,197
-3,219 Reduced 11.82%
24,006 $1.62 Million
Q2 2025

Aug 14, 2025

SELL
$59.83 - $87.57 $130,788 - $191,428
-2,186 Reduced 7.43%
27,225 $2.38 Million
Q1 2025

Jul 31, 2025

BUY
$67.74 - $90.75 $83,320 - $111,622
1,230 Added 4.36%
29,411 $2.01 Million
Q4 2024

Jul 31, 2025

BUY
$65.68 - $81.01 $1.62 Million - $1.99 Million
24,624 Added 692.27%
28,181 $2.19 Million
Q3 2024

Jul 31, 2025

SELL
$64.0 - $116.06 $552,576 - $1 Million
-8,634 Reduced 70.82%
3,557 $238,000
Q2 2024

Jul 31, 2025

BUY
$110.31 - $140.45 $255,919 - $325,844
2,320 Added 23.5%
12,191 $1.38 Million
Q1 2024

Jul 31, 2025

BUY
$114.22 - $140.1 $272,757 - $334,558
2,388 Added 31.91%
9,871 $1.37 Million
Q4 2023

Jul 31, 2025

BUY
$75.49 - $124.16 $18,646 - $30,667
247 Added 3.41%
7,483 $928,000
Q3 2023

Jul 31, 2025

SELL
$86.06 - $137.93 $93,116 - $149,240
-1,082 Reduced 13.01%
7,236 $675,000
Q2 2023

Jul 31, 2025

BUY
$112.47 - $130.98 $331,111 - $385,605
2,944 Added 54.78%
8,318 $1.07 Million
Q1 2023

Jul 31, 2025

BUY
$104.0 - $122.92 $209,768 - $247,929
2,017 Added 60.08%
5,374 $624,000
Q4 2022

Feb 06, 2023

SELL
$84.98 - $122.67 $11,982 - $17,296
-141 Reduced 4.03%
3,357 $380,000
Q3 2022

Nov 01, 2022

BUY
$76.35 - $94.18 $56,193 - $69,316
736 Added 26.65%
3,498 $282,000
Q2 2022

Jul 18, 2022

BUY
$67.99 - $132.89 $123,333 - $241,062
1,814 Added 191.35%
2,762 $206,000
Q1 2022

May 16, 2022

SELL
$94.08 - $130.2 $1,411 - $1,952
-15 Reduced 1.56%
948 $485,000
Q4 2021

Feb 08, 2022

BUY
$129.87 - $162.82 $16,103 - $20,189
124 Added 14.78%
963 $517,000
Q2 2021

Aug 03, 2021

BUY
$80.99 - $107.93 $1,457 - $1,942
18 Added 2.19%
839 $358,000
Q1 2021

May 12, 2021

BUY
$84.79 - $104.74 $69,612 - $85,991
821 New
821 $295,000
Q4 2020

Feb 16, 2021

SELL
$78.0 - $104.5 $51,012 - $68,343
-654 Closed
0 $0
Q3 2020

Dec 03, 2020

BUY
$95.51 - $112.95 $62,463 - $73,869
654 New
654 $270,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $22.4B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Brinker Capital Investments, LLC Portfolio

Follow Brinker Capital Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brinker Capital Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brinker Capital Investments, LLC with notifications on news.